Key facts
- This page summarizes Eric Groen's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Mar 2023, 21:12.
Eric Groen - 27 Mar 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)
- Reporting relationship
- GENERAL COUNSEL
- Issuer ticker
- RANI
- Reported as of
- 27 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Mar 2023, 21:12:44 UTC
- Prior SEC filing
- 24 Mar 2023
- Next SEC filing
- 19 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Josh Seidenfeld, , Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Groen filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 29 Mar 2023.
Change
- Previous filing in this sequence was filed on 24 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RANI
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +139,000
- Change %
- +574%
- Price
- $0.000000
- Shares after
- 163,216
- Date
- 27 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RANI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +205,800
- Change %
- Price
- $0.000000
- Shares after
- 205,800
- Date
- 27 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 205,800
- Exercise price
- $5.44
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
Footnote F2
The shares subject to the option vest as follows: 1/4th of the shares subject to the option vest monthly over four years from March 27, 2023.